Rheumatology Advance Access originally published online on November 23, 2004
Rheumatology 2005 44(3):293-298; doi:10.1093/rheumatology/keh473
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology Vol. 44 No. 3 © British Society for Rheumatology 2004; all rights reserved
The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis
1 The Laboratory for Rheumatic Diseases, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN). 1–7–22 Suehiro, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, and 2 Department of Allergy and Rheumatology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Correspondence to: X. Chang. E-mail: xchang{at}src.riken.go.jp
Objective. The gene for peptidylarginine deiminase 4 (PADI4) has been found to be closely associated with rheumatoid arthritis (RA). Peptidylarginine deiminase (PADI) catalyses the post-translational modification of peptidylarginine to citrulline, a reaction known as citrullination. PADI extracted from rabbit muscle has been reported to citrullinate antithrombin, a principal plasma inhibitor of thrombin. Thrombin is known to induce angiogenesis, fibrin formation and inflammation, the primary events of the RA joint. Here, we investigate whether human PADI4 can inhibit antithrombin by catalysing antithrombin citrullination and how the enzyme is involved in RA pathogenesis.
Methods. Antithrombin was incubated with recombinant PADI4 protein, and the inactivation of antithrombin was determined by reduction of its thrombin-inhibiting activity. Citrullination of antithrombin was detected by western blotting and enzyme-linked immunosorbent assay (ELISA). In addition, the citrullination level, activity and concentration of antithrombin in RA plasma were investigated by sandwich ELISA.
Results. Incubation of antithrombin with PADI4 resulted in loss of thrombin-inhibitory activity and in citrullination of antithrombin. RA plasma showed higher levels of citrullinated antithrombin than controls with non-arthritis disease and healthy individuals.
Conclusion. The results indicate that PADI4 could inactivate antithrombin through citrullination. The abnormal expression or activation of PADI4 in RA synovium is suggested to be responsible for the high level of citrullinated antithrombin in RA plasma. Local inhibition of antithrombin activity in RA synovium might lead to the excessive angiogenesis, fibrin deposition and inflammation of the tissue.
KEY WORDS: Rheumatoid arthritis, Peptidylarginine deiminase 4 (PADI4), Antithrombin, Thrombin, Citrullination
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. GANDJBAKHCH, I. FAJARDY, B. FERRE, S. DUBUCQUOI, R.-M. FLIPO, N. ROGER, and E. SOLAU-GERVAIS A Functional Haplotype of PADI4 Gene in Rheumatoid Arthritis: Positive Correlation in a French Population J Rheumatol, May 1, 2009; 36(5): 881 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Proost, T. Loos, A. Mortier, E. Schutyser, M. Gouwy, S. Noppen, C. Dillen, I. Ronsse, R. Conings, S. Struyf, et al. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation J. Exp. Med., September 1, 2008; 205(9): 2085 - 2097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Chang, R. Yamada, A. Suzuki, Y. Kochi, T. Sawada, and K. Yamamoto Citrullination of fibronectin in rheumatoid arthritis synovial tissue Rheumatology, November 1, 2005; 44(11): 1374 - 1382. [Abstract] [Full Text] [PDF]
|
|